|
Phase I Trial of Targeted EGFR or ALK Therapy with Ipilimumab in Metastatic NSCLC with Long-Term Follow-Up |
|
|
|
Titel: |
Phase I Trial of Targeted EGFR or ALK Therapy with Ipilimumab in Metastatic NSCLC with Long-Term Follow-Up |
Auteur: |
Chalmers, Anna W. Patel, Shiven Boucher, Ken Cannon, Laura Esplin, Michelle Luckart, Julie Graves, Natalie Duren, Terry Van Akerley, Wallace |
Verschenen in: |
Targeted oncology |
Paginering: |
Jaargang 14 (2019) nr. 4 pagina's 417-421 |
Jaar: |
2019 |
Inhoud: |
|
Uitgever: |
Springer International Publishing, Cham |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|